Additional Oxerutin Therapy to Promote Deep Vein Thrombus Resolution – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Stephanie Carlin et al, adding:
“Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
Oxerutin therapy alongside standard treatment reduced residual venous obstruction in deep vein thrombosis patients, potentially lowering postthrombotic syndrome risk compared to standard treatment alone.”
Title: Association of direct oral anticoagulant–anticonvulsant coprescription with clinical outcomes in older adults: a population-based cohort study
Authors: Stephanie Carlin, Anne M. Holbrook, Matteo Candeloro, Francis Nguyen, Michael Paterson, James Douketis.
Read the Full Article on Journal of Thrombosis and Haemostasis.
Get the latest from Hemostasis Today.
-
Mar 23, 2026, 17:47Katherine Caster: Celebrating The Impact and Continued Leadership of AHA In The Fight Against Heart Disease and Stroke
-
Mar 23, 2026, 17:45Archil Jaliashvili: Oxygen’s Journey – 6 Critical Steps to Power the Cell
-
Mar 23, 2026, 17:42Ney Carter Borges: Contemporary Trends and Outcomes of Percutaneous Coronary Intervention for Stent Thrombosis
-
Mar 23, 2026, 17:42Gerrit M. Große: Key Biomarker Research Priorities from BIOSTROKE Collaboration
-
Mar 23, 2026, 17:42Advancing Access to Immunotherapy in Pediatric Oncology in Armenia Through ACT for Children – Yeolyan Hematology and Oncology Center
-
Mar 23, 2026, 17:39Shlomo Sadoun: Systemic Bias in Healthcare Delivery and Outcomes
-
Mar 23, 2026, 17:38Ken Checicki: Expanding Hemophilia Diagnosis in Nigeria Through Mobile Care
-
Mar 23, 2026, 17:36HFA and the Cambodia Hemophilia Association Announce Partnership to Strengthen Support for People with Bleeding Disorders
-
Mar 23, 2026, 17:33Ramy Abdelnaby: Let’s Prioritize Women’s Health In Neurological Care